165 related articles for article (PubMed ID: 3145352)
1. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
[No Abstract] [Full Text] [Related]
2. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
Homma JY; Tanimoto H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353
[No Abstract] [Full Text] [Related]
3. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
Homma JY; Tanimoto H
Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
[No Abstract] [Full Text] [Related]
4. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
[No Abstract] [Full Text] [Related]
5. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
[TBL] [Abstract][Full Text] [Related]
7. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F
Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810
[TBL] [Abstract][Full Text] [Related]
8. Development of antibodies to OEP, exotoxin A and exoenzymes of Pseudomonas aeruginosa in man.
Shinozaki T; Fujii R; Sanai Y; Homma JY
Jpn J Exp Med; 1981 Jun; 51(3):165-70. PubMed ID: 6795373
[TBL] [Abstract][Full Text] [Related]
9. [Prevelance of antibodies ot OEP, exotoxin A, and exoenzymes of Pseudomonas aeruginosa in man (author's transl)].
Shinozaki T; Fujii R; Sanai Y; Homma JY
Kansenshogaku Zasshi; 1981 Jan; 55(1):32-40. PubMed ID: 6788869
[No Abstract] [Full Text] [Related]
10. Responses of adult volunteers to a Pseudomonas aeruginosa exotoxoid-A vaccine.
Lydick E; Mclean AA; Woodhour AF; Callahan LT
J Infect Dis; 1985 Feb; 151(2):375. PubMed ID: 3918128
[No Abstract] [Full Text] [Related]
11. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients.
Trancassini M; De Vito D; Quattrucci S; Cipriani P
New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606
[TBL] [Abstract][Full Text] [Related]
12. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Cryz SJ; Fürer E; Sadoff JC; Germanier R
Antibiot Chemother (1971); 1987; 39():249-55. PubMed ID: 3118786
[No Abstract] [Full Text] [Related]
13. [The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa].
Steuhl KP; Döring G; Thiel HJ
Fortschr Ophthalmol; 1989; 86(4):283-6. PubMed ID: 2507425
[TBL] [Abstract][Full Text] [Related]
14. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model.
Gilleland HE; Gilleland LB; Fowler MR
J Med Microbiol; 1993 Feb; 38(2):79-86. PubMed ID: 8429543
[TBL] [Abstract][Full Text] [Related]
15. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].
Dmitriev BA; Kul'shin VA; Antsiferova NG; Vovk VA; Moroz AF
Dokl Akad Nauk SSSR; 1988; 298(5):1277-80. PubMed ID: 2454182
[No Abstract] [Full Text] [Related]
16. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
Pier GB
Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204
[No Abstract] [Full Text] [Related]
17. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A].
Brodinova NS; Vovk VA; Aleksandrov AD; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376
[TBL] [Abstract][Full Text] [Related]
18. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
Coin D; Vacheron MJ; Guinand M; Michel G
FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
[TBL] [Abstract][Full Text] [Related]
19. Identification of a small epitope in domain Ib of Pseudomonas aeruginosa exotoxin A that elicits enzyme-neutralizing antibodies.
Rutault K; Coin D; Vacheron MJ; Guinand M; Wallach J; Michel G
FEMS Microbiol Immunol; 1992 Jul; 4(5):267-72. PubMed ID: 1381199
[TBL] [Abstract][Full Text] [Related]
20. [Isolation of different variants of Pseudomonas aeruginosa anatoxin and their characteristics].
Brodinova NS; Levdikova GA; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):6-12. PubMed ID: 2438865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
